Antimicrobials articles within Nature Materials

Featured

• Editorial | 23 July 2020

  COVID-19 therapies and vaccine landscape

  Within a few weeks of the novel coronavirus genome sequence being published, numerous therapies and vaccines have entered clinical trials with a few showing great promise in alleviating symptoms and accelerating recovery.

• News & Views | 23 October 2018

  Targeting vesicle size

  An amphipathic peptide has been engineered and is capable of penetrating the blood–brain barrier as well as possessing a potent antiviral activity against Zika and other mosquito-borne viruses.

  • Jing Zou
  •  & Pei-Yong Shi

• Letter | 22 October 2018

  Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide

  The Zika virus infects the central nervous system and results in severe brain malformation. An amphiphatic peptide is now shown to penetrate the blood–brain barrier, reducing viral loads due to its activity against Zika and other mosquito-borne viruses.

  • Joshua A. Jackman
  • , Vivian V. Costa
  •  & Nam-Joon Cho

• News & Views | 23 January 2018

  Broad-spectrum antivirals

  Nanoparticle mimics of heparan sulfate proteoglycans offer a new strategy for the inhibition of a range of viral infections.

  • Benson J. Edagwa
  •  & Howard E. Gendelman

• Article | 18 December 2017

  Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism

  Antiviral nanoparticle-formulated mimics of heparan sulfate proteoglycans were developed and shown to permit strong viral association as well as inhibition of a range of viruses on in vitro and in vivo models of infection.

  • Valeria Cagno
  • , Patrizia Andreozzi
  •  & Francesco Stellacci

• Research Highlights | 21 August 2014

  Resolved by gold

  • Luigi Martiradonna